MOG and myeloid sarcoma: No significant differences were observed when considering the ratio of rh-MOG-stimulated-Th17 cells to unstimulated-ones among the three groups (means: 1.95 ± 0.44; 1.47 ± 0.28 and 1.6 ± 0.45 in MOGAD, MS and control, respectively) (Figure 1E).